Estimates Revisions Astellas Pharma Inc. Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG 23:46:35 27/08/2026 +04			5-day change	1st Jan Change
12.60 ^EUR	-1.56%		+2.44%	+13.21%

12:09pm	Astellas' Profits May Have Doubled, But Can It Outrun the Street's Skepticism?
08-25	Astellas Pharma Inc. Doses First Patient In Phase 3 Study Of ASP2138 In Combination With Chemotherapy And Pembrolizumab As First-Line Treatment In Adults With Locally Advanced Unresectable Or Metastatic Gastric Or Gastroesophageal Junction Adenocarcinoma	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	ELI LILLY AND COMPANY
	JOHNSON & JOHNSON
	ABBVIE INC.
	ROCHE HOLDING AG
	NOVARTIS AG
	ASTRAZENECA PLC
	AMGEN INC.
	NOVO NORDISK A/S
	GILEAD SCIENCES, INC.
	Average
	Weighted average by Cap.